Sci Pharmtech (TPE:4119) E10: NT$3.54 (As of Dec. 2025)


TPE:4119 Sci Pharmtech Inc TPE:4119
67 GF Score
Price NT$44.50
GF Value NT$96.43
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Sci Pharmtech E10?

Sci Pharmtech TPE:4119 -0.34% 67 E10 is NT$3.54 as of Dec. 2025. GuruFocus rates TPE:4119 with a GF Score™ of 67/100 and a GF Value™ of NT$96.43 (Possible Value Trap). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sci Pharmtech's adjusted earnings per share data for the three months ended in Dec. 2025 was NT$0.330. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$3.54 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Sci Pharmtech's average E10 Growth Rate was -7.30% per year. During the past 3 years, the average E10 Growth Rate was 0.90% per year. During the past 5 years, the average E10 Growth Rate was 3.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Sci Pharmtech was 5.20% per year. The lowest was 0.90% per year. And the median was 4.50% per year.

As of today (2026-06-28), Sci Pharmtech's current stock price is NT$44.50. Sci Pharmtech's E10 for the quarter that ended in Dec. 2025 was NT$3.54. Sci Pharmtech's Shiller PE Ratio of today is 12.57.

During the past 13 years, the highest Shiller PE Ratio of Sci Pharmtech was 33.24. The lowest was 11.41. And the median was 23.45.


Sci Pharmtech  (TPE:4119) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sci Pharmtech's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=44.50/3.54
=12.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Sci Pharmtech was 33.24. The lowest was 11.41. And the median was 23.45.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Sci Pharmtech E10 Related Terms


Sci Pharmtech E10 Historical Data

* Premium members only.

The historical data trend for Sci Pharmtech's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sci Pharmtech E10 Chart

Sci Pharmtech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.28 3.45 3.60 3.82 3.54

Sci Pharmtech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.82 3.78 3.67 3.59 3.54

TPE:4119 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sci Pharmtech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sci Pharmtech Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sci Pharmtech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sci Pharmtech's Shiller PE Ratio falls into.


TPE:4119
67GF Score
Sci Pharmtech Inc TPE:4119
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sci Pharmtech E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sci Pharmtech's adjusted earnings per share data for the three months ended in Dec. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=0.33/324.0540*324.0540
=0.330

Current CPI (Dec. 2025) = 324.0540.

Sci Pharmtech Quarterly Data

per share eps CPI Adj_EPS
201603 1.444 238.132 1.965
201606 1.203 241.018 1.617
201609 0.860 241.428 1.154
201612 0.299 241.432 0.401
201703 0.467 243.801 0.621
201706 0.365 244.955 0.483
201709 0.372 246.819 0.488
201712 0.540 246.524 0.710
201803 0.562 249.554 0.730
201806 1.364 251.989 1.754
201809 1.159 252.439 1.488
201812 0.992 251.233 1.280
201903 1.495 254.202 1.906
201906 1.437 256.143 1.818
201909 1.458 256.759 1.840
201912 0.817 256.974 1.030
202003 1.896 258.115 2.380
202006 2.210 257.797 2.778
202009 1.724 260.280 2.146
202012 -2.555 260.474 -3.179
202103 0.376 264.877 0.460
202106 0.035 271.696 0.042
202109 0.271 274.310 0.320
202112 -0.184 278.802 -0.214
202203 0.376 287.504 0.424
202206 1.146 296.311 1.253
202209 0.443 296.808 0.484
202212 0.763 296.797 0.833
202303 0.590 301.836 0.633
202306 1.860 305.109 1.975
202309 0.330 307.789 0.347
202312 -0.080 306.746 -0.085
202403 0.370 312.332 0.384
202406 0.520 314.175 0.536
202409 3.180 315.301 3.268
202412 0.390 315.605 0.400
202503 0.260 319.799 0.263
202506 0.190 322.561 0.191
202509 0.120 324.800 0.120
202512 0.330 324.054 0.330

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of NT$3.54 mean?
Sci Pharmtech (TPE:4119) has a E10 of NT$3.54 as of Dec. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Sci Pharmtech and its competitors.
Is Sci Pharmtech's E10 too high?
Sci Pharmtech's current E10 is NT$3.54. Overall, Sci Pharmtech has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sci Pharmtech's E10 compare to ZTS?
Sci Pharmtech's E10 of NT$3.54 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Sci Pharmtech and its competitors. Sci Pharmtech's current E10 is NT$3.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sci Pharmtech stock overvalued right now?
Based on GuruFocus' analysis, Sci Pharmtech (TPE:4119) is currently considered Possible Value Trap. The stock's GF Value™ is NT$96.43, compared to a current price of NT$44.50 — trading 53.9% below its estimated fair value. The current E10 is NT$3.54. Sci Pharmtech's overall GF Score™ is 67/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Sci Pharmtech (TPE:4119), the current E10 is NT$3.54 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sci Pharmtech (TPE:4119) Overvalued in 2026?

Based on GuruFocus' analysis, Sci Pharmtech stock appears to be undervalued. The current stock price of NT$44.50 is trading 53.9% below its estimated GF Value™ of NT$96.43. GuruFocus considers Sci Pharmtech to be Possible Value Trap.

Key valuation signals for TPE:4119:

  • E10: NT$3.54
  • GF Value™: NT$96.43 vs. price of NT$44.50 (53.9% below fair value)
  • GF Score™: 67/100 with 8 warning signs

No single metric tells the full story. See the TPE:4119 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sci Pharmtech Business Description

Address No.61, Lane 309, Haihu North Road, Luzhu District, Taoyuan, TWN, 33856
Sci Pharmtech Inc is engaged in the research and development, manufacture, and sales of active pharmaceutical ingredients, intermediates, and specialty chemicals. Geographically, the primary markets of the company are Italy, Germany, Japan, Taiwan, the United States, Switzerland, Spain, Belgium, Netherlands, and others.
67GF Score

Get the complete analysis for TPE:4119

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$44.50
Price
NT$96.43
GF Value